Ladder Bio (formerly ThirdLaw Technologies) has pioneered the development of Spiroligomer™ molecules and is developing this innovative, patent-protected, therapeutic modality into a new class of more targeted medicines. The mission of Ladder Bio is to create a revolutionary category of molecules that transform how diseases are diagnosed and treated – more safely and effectively.

ThirdLaw Molecular, Inc. announced its new name change, Ladder Bio Inc., reflecting the company’s mission to pioneer Spiroligomer™ therapeutics ("ladder-shaped peptide-like molecules"), a novel therapeutic modality for new medicines.